Earnings Call · Q1 FY2022·2022-05-03

Q1 22EPS -0.96%·Rev n/aQ4 21EPS +6.59%·Rev n/aQ3 21EPS +15.66%·Rev n/aQ2 21EPS +5.41%·Rev n/a⚠ consensus missing

RHYTHM PHARMACEUTICALS, INC. RYTM

David Connolly — Head of IR and Corporate Communications

David Meeker — Chief Executive Officer

Jennifer Chien — Chief Commercial Officer

Linda Shapiro — Chief Medical Officer

Hunter Smith — Chief Financial Officer

−2.7%1d on move date−3.2% vs SPY3d−23.2%5d−41.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RYTM calls or request research access.

More RYTM calls Browse calls Request research access